Skip to main content
GBCS
OTC Real Estate & Construction

CEO and CFO Adam Desmond Resigns Amidst Financial Uncertainty; Krystal Eckhart Appointed Interim

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Real Estate
Sentiment info
Negative
Importance info
9
Price
$3.55
Mkt Cap
$10.888M
52W Low
$0.405
52W High
$6.25
52W Position info
777% above low
Off High info
43% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

GBCS has more than doubled off its 52-week low of $0.405.

Summary

Selectis Health's CEO and CFO, Adam Desmond, has resigned, receiving a $40,000 severance, with Krystal Eckhart appointed as interim replacement, amidst ongoing financial challenges and a recently failed acquisition bid.


Key Events · Executive and Board Changes · GBCS

  • CEO and CFO Resignation

    Adam Desmond resigned from all positions, including CEO, CFO, and Board member, effective May 14, 2026.

  • Interim Leadership Appointed

    Krystal Eckhart, a current Vice President of Revenue Management, was appointed Interim CEO and CFO effective May 15, 2026.

  • Severance Agreement

    Desmond received a $40,000 severance payment as part of a separation agreement.

  • Context of Instability

    This leadership change follows the recent termination of a tender offer and prior disclosures of going concern doubts and material weaknesses in internal controls.


Analysis · GBCS · Real Estate & Construction

The departure of CEO and CFO Adam Desmond, following the termination of a tender offer and the company's disclosure of going concern doubts and material weaknesses, signals significant leadership instability. The appointment of an internal Vice President as interim CEO and CFO suggests a transitional period during a critical time for the micro-cap company.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 52.4% of the 208 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -1.91%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, GBCS was trading at $3.55 on OTC in the Real Estate & Construction sector, with a market capitalization of approximately $10.9M. The 52-week trading range was $0.41 to $6.25. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

GBCS - Latest Insights

GBCS
Oct 09, 2026, 4:54 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $5.73
Real-time Price: $5.73 info
Change: $0 (0%) info
Market Cap: $17.574M info
GBCS
Sep 08, 2026, 9:36 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $5.74
Real-time Price: $5.73 info
Change: -$0.0100 (-0.17%) info
Market Cap: $17.574M info
GBCS
Sep 04, 2026, 6:30 PM EDT
Filing Type: SC TO-T/A
Importance Score:
8
Price at Filing: $5.74
Real-time Price: $5.73 info
Change: -$0.0100 (-0.17%) info
Market Cap: $17.574M info
GBCS
Aug 24, 2026, 5:23 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $5.42
Real-time Price: $5.73 info
Change: +$0.310 (+6%) info
Market Cap: $17.574M info
GBCS
Aug 11, 2026, 4:30 PM EDT
Filing Type: SC TO-T/A
Importance Score:
7
Price at Filing: $5.65
Real-time Price: $5.73 info
Change: +$0.080 (+1%) info
Market Cap: $17.574M info